Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Cabozantinib for Patients with Liver Cancer Not Responding to Previous Immune Treatments
ItalyStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer
ItalyStudy on Guselkumab for Healing in Crohn's Disease Patients
ItalyStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
ItalyStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
ItalyStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
ItalyStudy of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions
ItalyStudy on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1
ItalyStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
ItalyStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
ItalyStudy on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
ItalyStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
